Alyeska Investment Group L.P. trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 39.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,579,334 shares of the real estate investment trust's stock after selling 1,012,439 shares during the quarter. Alyeska Investment Group L.P. owned approximately 0.23% of Healthpeak Properties worth $31,934,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of DOC. TCTC Holdings LLC raised its holdings in shares of Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares in the last quarter. Brooklyn Investment Group raised its holdings in shares of Healthpeak Properties by 198.9% in the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 873 shares in the last quarter. Future Financial Wealth Managment LLC acquired a new stake in shares of Healthpeak Properties in the 1st quarter valued at $30,000. S.A. Mason LLC raised its holdings in shares of Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Finally, Dagco Inc. acquired a new stake in shares of Healthpeak Properties in the 1st quarter valued at $30,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of brokerages have recently weighed in on DOC. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their price objective for the company from $21.00 to $19.00 in a research note on Tuesday, July 29th. Finally, Morgan Stanley decreased their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $21.50.
Check Out Our Latest Analysis on Healthpeak Properties
Insider Buying and Selling
In other Healthpeak Properties news, CEO Scott M. Brinker acquired 2,930 shares of the company's stock in a transaction on Thursday, July 31st. The shares were bought at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer owned 210,416 shares in the company, valued at $3,589,696.96. This trade represents a 1.41% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders have acquired 8,783 shares of company stock valued at $150,129 in the last quarter. Insiders own 0.23% of the company's stock.
Healthpeak Properties Stock Performance
NYSE DOC traded down $0.28 during trading hours on Tuesday, hitting $18.02. The company had a trading volume of 2,352,586 shares, compared to its average volume of 6,069,339. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26. The company has a market cap of $12.52 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 2.37 and a beta of 1.07. The business has a 50 day moving average of $17.77 and a 200-day moving average of $18.22.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties's revenue for the quarter was down .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The firm also recently disclosed a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were paid a $0.1017 dividend. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.8%. Healthpeak Properties's payout ratio is currently 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.